Aetiology of liver disease and response to immune checkpoint inhibitors: An updated meta-analysis confirms benefit in those with non-viral liver disease

J Hepatol. 2023 Aug;79(2):e73-e76. doi: 10.1016/j.jhep.2023.04.012. Epub 2023 Apr 21.
No abstract available

Publication types

  • Meta-Analysis
  • Letter

MeSH terms

  • Causality
  • Humans
  • Immune Checkpoint Inhibitors* / therapeutic use
  • Liver Diseases* / drug therapy
  • Liver Diseases* / etiology

Substances

  • Immune Checkpoint Inhibitors